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Abstract
Foxp3
+ CD4
+ regulatory T cells represent a T cell subset with well-characterized immunosuppressive effects during immune
homeostasis and chronic infections, and there is emerging evidence to suggest these cells temper pulmonary inflammation in
response to acute viral infection. Recent studies have demonstrated treatment with PC61 CD25-depleting antibody potentiates
inflammation in a murine model of RSV infection, while paradoxically delaying recruitment of CD8
+ Tc e l l st ot h es i t eo f
inflammation. The present study therefore sought to examine the role of these cells in a murine model of acute influenza A virus
infection through the administration of PC61 CD25-depleting antibody. PC61 antibody is able to partially deplete CD25
+Foxp3
+
regulatory T cells to a comparable degree as seen within previous work examining RSV, however this does not alter influenza A-
virus induced mortality, weight loss, viral clearance and cellularity within the lung. Collectively, these data demonstrate that
partial depletion of CD4
+CD25
+ regulatory T cells with PC61 antibody does not alter the course of influenza A virus infection.
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Introduction
Regulatory T (Treg) cells are a subset of T lymphocytes capable
of moderating inflammatory responses to both foreign and self-
antigens, and thus represent a principal mechanism of immune
suppression. A diverse assortment of Treg cells have been described
in both CD4
+ and CD8
+ T cell subsets, however to date most Treg-
mediated suppression within mice involves Treg cells expressing the
CD4 co-receptor and characteristic transcription factor Foxp3.
Within the CD4
+Foxp3
+ Treg cells there are believed to be two
major subset of Treg cells; natural Treg cells, derived from high-
avidity selection for self-antigens within the thymus, and induced
Treg cells, which are generated in the periphery from CD4
+Foxp3
-
precursors during the course of inflammation [1,2,3]. Depletion of
Treg cells using a-CD25 antibody PC61 represents a common
method of depleting CD25
+ regulatory T cells, albeit with the
potential complication of depletion of natural killer (NK) cells, B
cells and effector CD4
+ T cells bearing CD25 [4].
While there is a growing body of evidence to implicate adaptive
Foxp3
+ Treg cells in tumor resistance to effector responses and
various chronic inflammatory conditions including chronic viral
infection [5,6], little is known about the function of Foxp3
+ Treg
cells within acute viral infections, and the role of Treg cells in
respiratory viral infection remains poorly defined. A recent series
of reports have examined the role of Treg cells in acute respiratory
syncytial virus infection, a respiratory virus that induces a mixed
Th1/Th2 response during infection [7]. Depletion of Treg cells
using PC61 Treg-depleting antibody within RSV infection results
in impaired recruitment of antigens-specific CD8
+ T cells to the
lung, while reducing the MHC class I immunodominance
hierarchy between the dominant K
d-restricted M2 epitope
towards the sub-dominant D
bM187-195 epitope [8,9]. While
Treg-depleted mice exhibit delayed CD8
+ T cell infiltration
kinetics, responding CD8
+ T cells produce higher levels of pro-
inflammatory cytokines and persist longer in the lung following
infection. These data suggest that natural Treg cells assist with the
co-ordination of the initial adaptive immune response, but also
attenuate inflammation towards the latter stages of infection.
Depletion of natural Tregs also results in potentiated innate
immunity to RSV, characterized by increased BAL cellularity and
elevated cytoktine and chemokine production [10].
While depletion of Treg cells using CD25-depleting antibody
results in increased CD8
+ T cell proliferation, IFN-c production
and cytolytic activity in response to influenza antigens within a
murine model of chronic inflammatory bowel disease [11], to date
there are very few studies examining regulatory T cells within
influenza infection. Longhi and colleagues examined the ability of
Treg cells from the spleens of influenza-infected animals to
suppress antigen-specific CD4
+ proliferation at later timepoints,
and suggest that IL-6 acts to inhibit the priming of antigen-specific
Tregs thus allowing an unconstrained primary CD8
+ T cell
response [12]. Antunes and co-workers noted that adoptive
transfer of polyclonal Treg cells into influenza-infected, lympho-
cyte-deficient mice prolongs survival and attenuates the innate
response, demonstrating that Treg cells are capable of altering
influenza-induced immunity at least under some circumstances
[13]. The present study therefore sought to determine the role of
regulatory T cells on the course of influenza A virus infection
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infection results in the robust induction of a CD4
+Foxp3
+CD25
+
regulatory T cell response. While PC61 CD25-antibody is
moderately successful at depleting Treg cells, there is no alteration
to clinical signs, viral load or inflammation during infection. These
indicate that partial depletion of Treg cells using PC61 antibody
does not alter influenza A-virus induced inflammation.
Results
Influenza A virus-induced regulatory T cells express high
levels of CD25
As the present study sought to eliminate regulatory T cells
using a-CD25 (PC61) antibody, it was necessary to examine the
expression of CD25 on influenza A virus-induced Treg cells. At
the site of inflammation there is a preferential recruitment of
Treg cells at early timepoints, with the peak proportion of CD4
+
T cells expressing Foxp3 being at day 7 within the lung, while
the proportion of Treg cells falls within the draining lymph node
at day 7 (Fig. 1B). Initially, only ,75% of Treg cells within the
lung express CD25, increasing to ,90% by day 7 post-
inoculation. In both BAL and lung the proportion of Foxp3
+
expressing CD25 remain elevated at day 11 before decreasing at
day 14 post-inoculation (Fig. 1C). These findings suggest Treg
cells induced within influenza will be susceptible to a-CD25
PC61-mediated depletion, but that a sizeable proportion of
Foxp3
+CD25
- cells may remain and represent a possible
confounding factor.
Figure 1. Influenza A virus infection results in the robust induction of a CD25
+Foxp3
+ Treg response. Mice were inoculated with 10pfu
influenza A/PR8/34 and sacrificed at various timepoints and the induction of CD25
+Foxp3
+ Treg cells determined across the course of infection. (A)
Representative FACS plots of the proportion of T cells collected from BAL expressing CD25 and Foxp3, gated on CD3 and CD4 positive cells. (B)
Proportion of CD3
+CD4
+ T cells expressing Foxp3
+ across a timecourse in cells collected from BAL, lung, and mediastinal lymph node. (C) Proportion
of Foxp3
+ Tregs that co-express CD25
+ across a timecourse in cells collected from BAL, lung, and mediastinal lymph node. (D) Total numbers of
CD25
+Foxp3
+ and CD25-Foxp3
+ T cells across a timecourse in cells collected from BAL, lung, and mediastinal lymph node. Data represents mean 6
S.E.M, n=4–7 for all.
doi:10.1371/journal.pone.0027849.g001
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by PC61 antibody
We next administered mice PC61 CD25-depleting antibody to
influenza A virus-infected mice twice, at days -2 and 4 post-
inoculation via the tail vein, and the mice were sacrificed at day 7 or
day 12 post-inoculation. A dual dose protocol was used as
preliminary experiments revealed a single injection of PC61 was
ineffective as reducing Treg numbers by day 7 post-inoculation
(data not shown). At day 7 post-inoculation lung and BAL Foxp3
+
Treg numbers has only been modestly reduced by ,30%, in
contrast to the ,65% depletion observed within the draining lymph
node (Fig. 2B). Depletion was more extensive within the lung and
BAL by day 12 post-inoculation, with ,60% Treg reduction.
Few Foxp3
+ Treg cells within the lung and mLN stained
positive for CD25 at day 7 post-inoculation, suggesting extensive
binding of PC61 antibody to target CD25 (Fig. 2C). Approxi-
mately 40% of Treg cells within the BAL stained positive for
CD25 however, demonstrating that PC61 antibody may not be
penetrating the BAL compartment efficiently at early timepoints
which may account for the inefficient BAL Treg depletion at day 7
post-inoculation (Fig. 2C). Foxp3
+CD25
+ proportions had begun
to recover by day 12 however, presumably as circulating antibody
levels are reduced. BAL Foxp3
+CD25
+ proportions were reduced
however, possibly a reflection of the reduced amount of Treg cells
expressing CD25 at the latter stages of infection. Collectively these
results demonstrate PC61 administration results in a moderate
degree of Treg depletion within influenza infection, and is more
effective at later timepoints.
Partial depletion of Treg cells does not alter influenza A-
virus induced weight loss or mortality
Having established PC61 antibody administration results in a
reduction of Treg numbers, we sought to determine if depletion of
Treg cells alters influenza A-virus induced weight loss and
mortality. Sublethal infection influenza A virus infection resulted
in progressive weight loss up to day 9 post-inoculation, after which
the mice had recovered by day 18 post-inoculation (Fig. 3A).
Administration of PC61 antibody did not alter influenza A virus-
induced weight loss within sub-lethal infection (Fig. 3A). At a lethal
dose of 250pfu/mouse, PC61 administration similarly did not alter
influenza A virus-induced mortality (Fig. 3B).
Partial depletion of regulatory T cells does not alter
influenza A virus-induced pulmonary inflammation
Previous studies examining the role of Treg cells within RSV
have noted potentiated pulmonary inflammation with the BAL
fluid of Treg-depleted mice. We therefore treated influenza A
virus-inoculated mice with PC61 antibody and examined BAL
cellularity using flow cytometry at days 7 and 12 post-inoculation,
to coincide with the timepoints at which Treg infiltration is
proportionally at its greatest and with the peak of adaptive
immune response, respectively. Surprisingly, treatment with PC61
antibody did not alter pulmonary infiltration of neutrophils,
macrophages and lymphocytes at both time-points examined
(Fig. 4A & B). As depletion of regulatory T cells has been shown to
alter antigen-specific CD8
+ T cell infiltration, we examined the
numbers of influenza antigen-specific CD8
+ T cells specific for
Figure 2. PC61 a-CD25 antibody administration results in partial depletion of Foxp3
+ regulatory T cells. Mice were inoculated with
10pfu influenza A/PR8/34 and administered PBS or 400 mg of PC61 antibody i.v. at days -2 and 4 post-inoculation, and expression of CD25
+ and
Foxp3
+ within CD3
+CD4
+ T cells examined at days 7 and 12 post-inoculation within lung, BAL and mLN samples. (A) Representative FACS plots of
CD25 and Foxp3 expression on BAL CD3
+CD4
+ T cells at days 7 and 12 post-inoculation in PC61 and PBS-injected mice. (B) Percentage of CD4
+ T cells
expressing Foxp3
+ in cells collected from lung, BAL and mLN of PBS and PC61 treated mice at days 7 and 12 post-inoculation. (C) Percentage of
CD4
+Fopx3
+ T cells co-expressing CD25 in PBS and PC61 treated mice from lung, BAL and mLN of PBS and PC61 treated mice at days 7 and 12 post-
inoculation. * denotes t,0.05, ** t,0.01, Student’ t-test. Data represents mean 6 S.E.M, n=6–8 for all.
doi:10.1371/journal.pone.0027849.g002
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draining lymph node at days 7 and 12 post-inoculation.
Administration of PC61 did not alter the number of NP366
+CD8
+
Treg cells within either the draining lymph node or lung at both
time-points examined (Fig. 4C & D). While PC61 antibody bound
to target CD25 on the minority CD25
+ population of
CD4
+Foxp3
+ T cells at both timepoints examined (Fig. 4E), total
numbers of CD4
+Foxp3
- remained unchanged (Fig. 4F). PC61
administration did not alter NK cell activation as determined by
CD107a expression at day 2 post-inoculation (data not shown).
We also examined BAL levels of characteristic Th1 cytokine IFN-
c, which is produced in high levels within influenza infection [14].
IFN-c levels were unchanged by PC61 administration (Fig. 4G), as
were BAL serum albumin levels, a characteristic marker of
pulmonary immunopathology [15] (Fig. 4H). Viral clearance, as
measured by pulmonary viral load at day 7 post-inoculation, was
similarly unchanged (Fig. 4I). Collectively these results indicate
that administration of PC61 depleting antibody does not alter the
inflammatory response to influenza A virus infection.
Discussion
Influenza A virus infection results in a vigorous immune
response, with extensive early innate immunity characterized by
neutrophilia, leading to a robust adaptive immune response in
which large numbers of CD8
+ T cells infiltrate the site of infection.
While CD8
+ T cells are protective against illness and lung injury at
low pulmonary viral loads [16], at high viral loads they cause a
high degree of immunopathology that may lead to significant
morbidity and mortality [17]. With such virus-induced immune
dysregulation a prominent feature of the disease, we postulated
regulatory mechanisms such as the induction of a Treg response
during the course of influenza infection would be vital in balancing
the immune response to the virus. Within the present study
however we find no evidence that partial Foxp3
+ Treg cells
contribute to the pathogenesis of influenza A virus infection.
Our findings of the proportions of Foxp3
+ Treg cells expressing
CD25
+ are broadly consistent with those reported for RSV
infection [8,9,10], demonstrating that Treg cells induced during
influenza A virus infection are a viable target for depletion via a
CD25-depleting antibody. Despite using a higher dose of PC61
antibody than Lee and colleagues and a comparable dose to
Ruckwardt and co-workers however, we find Treg depletion to be
slightly less efficient within influenza A virus infection compared to
RSV, and similar to the case for RSV infection there remains a
substantial pool of Foxp3
+CD25
- Treg cells within all tissues
examined which represents a considerable confounding factor.
CD25 expression on Foxp3
+ cells is highly plastic [18,19], and
CD25 is not an absolute requirement for suppressive ability [20].
Foxp3
+CD25
- Treg cells that persist after depletion possess potent
regulatory function [21], and are capable of rapidly upregulating
CD25 following PC61 administration [22]. This incomplete
depletion therefore raises the possibility of underestimation of
the role Foxp3
+ Treg cells play within influenza infection.
Within the present study, depletion of Treg cells using PC61
antibody does not alter influenza-induced weight loss, pulmonary
viral clearance, immunopathology or lung cellularity. These
findings are surprising in light of previous studies utilizing similar
Treg depletion protocols within a murine model of RSV infection,
variously noting reduced viral loads, increase virus-induced weight
loss, potentiated inflammation and altered antigen-specific CD8
+
T cell kinetics [8,9,10]. Within murine models of RSV infection
there is comparatively limited viral replication and correspond-
ingly mild lung pathology [23], and within our hands RSV
infection results in a considerable milder disease state compared to
the high pathogenicity induced by the PR8 strain of influenza in
mice. A cross-comparison of BAL and lung cell counts obtained
within these RSV studies with those of our influenza study reveals
a stronger inflammation generated by Influenza A/PR8, with a
corresponding higher degree of virus-induced weight loss. As even
a small dose of influenza virus is capable of inducing a strong
inflammatory response within mice [24], the higher intrinsic
pathogenicity of influenza A virus may account of the attenuated
efficacy of PC61. From these results one can draw two possible
conclusions; that CD25
+Foxp3
+ Treg cells are not an influential
factor in the inflammatory response to influenza A virus, or that
the technical limitations of the PC61 CD25-depletion approach
results in insufficient Treg depletion, with Treg cell numbers not
being reduced the level required to observe effects. Previous
authors demonstrating comparable levels of Treg depletion to
those observed within the present study have frequently concluded
the former, that lack of efficacy of PC61 demonstrates the relative
unimportance of Treg cells within the relevant model of infectious
disease [25,26,27]. A recent study conducted by Li and co-workers
however has demonstrated that partial depletion of Treg cells
through PC61 does not alter tumor size within a murine
inoculated with M04 melanoma, but that 95% ablation through
the use of Foxp3-DTR transgenic animals results in complete
regression of large established tumors and an associated increase in
tumor-specific CD8
+ T cell infiltration [28]. These findings raise
the possibility that Treg cells are of greater importance within
Figure 3. PC61 a-CD25 antibody administration does not alter
influenza A virus-induced weight loss of influenza A-virus
induced mortality. Mice were inoculated with influenza A/PR8/34
and administered PBS or 400 mg of PC61 antibody i.v. at days -2 and 4
post-inoculation. (A) Influenza-induced weight loss in mice inoculated
with a sub-lethal dose of 10pfu influenza A virus and administered PBS
or 400 mg PC61 a-CD25 antibody. (B) Influenza A virus-induced
mortality in mice inoculated with lethal dose of 250pfu Influenza A
virus and administered PBS or 400 mg PC61 a-CD25 antibody. Data
represents mean 6 S.E.M, n=6 for all.
doi:10.1371/journal.pone.0027849.g003
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PLoS ONE | www.plosone.org 4 November 2011 | Volume 6 | Issue 11 | e27849Figure 4. PC61 a-CD25 antibody administration does not alter influenza A virus-induced BAL cellularity, antigen-specific CD8
+ T
cell numbers, CD4
+Foxp3
- T cell numbers, NK cell activation, IFN-c levels, immunopathology and pulmonary viral load. alter
influenza A virus-induced weight loss of influenza A-virus induced mortality. Mice were inoculated with influenza A/PR8/34 and
administered PBS or 400 mg of PC61 antibody i.v. at days -2 and 4 post-inoculation. (A) BAL cellularity as determined by flow cytometry at day 7 (A) or
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limitations have precluded the precise examination of their
contribution to resolving infection. We therefore are unable to
completely rule out a role of Treg cells within influenza, but note
that reduction of Treg cells to the levels achievable through PC61
depletion, and comparable to those observed within RSV models,
does not alter disease outcome. The findings by Antunes and
colleagues that adoptive transfer of Treg cells into lymphocyte-
deficient mice suggests that Treg cells are capable of modulating
influenza immune responses to some degree [13], however there
remains the possibility that the role of Treg cells within influenza is
dependent on experimental conditions.
In conclusion, within the present study we demonstrate that
administration of with PC61 a-CD25 results in partial depletion of
influenza A virus-induced Foxp3
+ Treg cells, but that despite
positive results obtained within other murine models of acute
respiratory viral infection this reduction in Treg cell numbers does
not alter the course of the disease. While we find no support for the
hypothesis that Treg cells are able to alter influenza A virus
infection, previous research examining regulatory T cells within
influenza and emerging data concerning the relative lack of
efficacy of PC61 antibody suggests these results should be
interpreted with caution.
Materials and Methods
Mice and virus stocks
C57BL/6 mice were purchased from Jackson Laboratories and
bred in-house at the National University of Singapore animal
facility. Mice were age and sex-matched for each experiment. All
experiments were carried out in accordance of the guidelines of
The National University of Singapore Advisory Committee for
Laboratory Animal Research (NACLAR) Singapore. The proto-
cols (protocol numbers 094/06 and 137/08) were approved by
Institutional Animal Care and Use Committee (IACUC) of the
National University of Singapore. Influenza A/PR/8/34 (H1N1)
was purchased from ATCC and propagated in the allantois of 10
day-old embryonated chicken eggs and stored at 280uC.
Mouse infection and treatment
Intranasal challenge of mice with influenza was performed by
injecting mice with ketamine (100 mg/kg, Sigma) and medotomi-
dine (15 mg/kg, Orion Pharma) i.p. and administering 10 pfu of
influenza in 20 ml volume i.n., after which mice were administered
atipamezole (5 mg/kg, Pfizer) reversal. In mortality experiments
mice were administered 250 pfu influenza A virus in 20ul. PC61
a-CD25 antibody was generated from hybridoma cells (ATCC) in
serum-free media (Gibco), and purified using HPLC. For Treg
depletion, mice were administered 400 mg of PC61 antibody in
PBS i.v. at days -2 and 4 post-inoculation. All animal experiments
were conducted in accordance with institutional guidelines.
T cell collection
Spleen, mediastinal lymph node (mLN) and mesenteric and
axillary non-draining lymph nodes (NDLN) were collected from
euthanized animals and pushed through a 61 mm cell strainer (BD
Falcon) to obtain a single cell suspension. BAL samples were
collected by 460.5 ml instillations of PBS through the trachea of
cannulated mice. Lung samples were digested for 45 minutes in
Liberase (Roche) at 37uC prior to being passed through a cell
strainer. Red blood cells were lysed using ammonium chloride.
Cell samples were washed with MACS buffer and stained for
surface markers CD3 (Clone 145-2C11, Biolegend) and CD4
(clone RM4-5, BD Pharmingen) and CD25 (Clone PC61,
Biolegend) for 30 mins. Cells were washed twice, fixed using
fixation/permeabilization buffer (BD Bioscience) for 1 hour,
washed twice in permeabilization buffer and stained for Foxp3
(Clone FKJ-16s, eBioscience) for 30 mins. Cells were washed twice
and examined on a CyAn flow cytometer (Beckman Coulter).
Antigen-specific CD8
+ T cell numbers were determined using
NP366 tetramer (Proimmune). NK cell activation status was
determined by activating ficoll-enriched lung cells with PMA
(50 gg/ml)/Ionomycin (400gg/ml) in the presence of a-CD107a
antibody, monensin (1 ml/ml) and brefeldin A (1 ml/ml) for
3.5 hours, after which they were stained for CD3, NK1.1 and
CD25.
BAL cellularity
BAL cellularity was determined by flow cytometry. In brief,
BAL samples obtained as described above, washed in MACS
buffer and stained for 30 mins within CD3 (T cells, Clone 145-
2C11, Biolegend), Ly6G (neutrophils, Clone EL-4J, Biolegends) or
CD11c (macrophages, Clone M5/114.15.2, Biolegend).
Cytokine and BAL Albumin ELISA
Cytokine levels were examined within BAL fluid by ELISA
(R&D Systems) according to manufacturers instruction, while BAL
albumin levels were determined using serum albumin ELISA kit
(Bethyl Laboratories). In brief, Immunosorb ELISA plates (Nunc)
were coated overnight with capture antibody, washed and blocked
with 1% BSA at room temperature for 1 hour. Samples or
standard were added for 2 hours, washed, and bound antibody
was detected using biotinylated anti-cytokine antibody, avidin
horseradish peroxidase and tetramethylbenzidine. Color develop-
ment was halted with 2M H2SO4 and optical density read at
450 nm.
Quantification of viral RNA
Mice were sacrificed and the left lung lobe removed and
homogenized within RNA later (Qiagen). Viral load was
determined using real-time quantitative PCR and influenza matrix
gene M1 as described elsewhere [29]. Data is expressed as a
percentage of GAPDH output.
Statistical analysis
Statistic analysis was performed using GraphPad Prism
(GraphPad Software). Pairwise comparisons were made using
Student’s t-test, while comparisons across groups were made using
day 12 (B) post-inoculation in mice administered PBS or PC61 a-CD25 antibody. Antigen-specific CD8
+ T cell numbers in lung (C) or mLN (D) at days 7
and 12 post-inoculation in mice administered PBS or PC61 antibody. (E) Percentage of CD4
+Foxp3
- T cells expressing CD25 and (F) total CD4
+Foxp3
- T
cell numbers at days 7 and 12 post-inoculation in mice treated with PBS or PC61 antibody. (G) Percentage NK cells expressing activation marker
CD107a at day 2 post-inoculation in mice administered 400 mg of PC61 antibody i.v. at days -2 post-inoculation. (H) IFN-c levels in BAL fluid at days 7
and 12 post-inoculation in mice administered PBS or 400 mg of PC61 antibody i.v. at days -2 and 4 post-inoculation. (I) BAL albumin at days 7 and 12
post-inoculation in mice administered PBS or 400 mg of PC61 antibody. (J) Pulmonary viral titre at day 7 post-inoculation in mice administered PBS or
PC61 antibody. Data represents mean 6 S.E.M, n=5–7 for all.
doi:10.1371/journal.pone.0027849.g004
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